Detected ·
Abcuro, Inc
$66M—
Abcuro, Inc raised $66M in Series D financing led by New Leaf Venture Partners, with participation from Bain Capital, Samsara BioCapital, ShangBay Capital, and others, to advance ulviprubart for Inclusion Body Myositis.
- Website
- www.abcuro.com
- linkedin.com/company/abcuro-inc
- Amount
- $66 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-19 12:03:44 UTC
- Signal ID
- 148d28ce-3906-43ed-b3e8-6e5ca3a17025
As the API returns it
{
"id": "148d28ce-3906-43ed-b3e8-6e5ca3a17025",
"created_at": "2026-08-19T12:03:44.234122Z",
"company_name": "Abcuro, Inc",
"company_website_url": "www.abcuro.com",
"company_linkedin_url": "https://www.linkedin.com/company/abcuro-inc",
"event_type": "funding",
"funding_amount": 66000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Abcuro, Inc raised $66M in Series D financing led by New Leaf Venture Partners, with participation from Bain Capital, Samsara BioCapital, ShangBay Capital, and others, to advance ulviprubart for Inclusion Body Myositis.*"
}